15 November 2022 : Clinical Research
Suppression of Tumorigenicity 2 Pro-Inflammatory Biomarker Linking Diabetes Mellitus and Periodontitis: A Pilot Study
Paladugu Devi Navya1CDF*, Gurumoorthy Kaarthikeyan1CEF, Selva Raj J.2BCDE, Ahmed Alamoudi3AEF, Maha A. Bahammam45CEF, Bassam Zidane6BDE, Hammam Ahmed BahammamDOI: 10.12659/MSM.938218
Med Sci Monit 2022; 28:e938218
Table 2 Comparative analysis of levels of suppression of tumorigenicity 2 (ST2) between groups using one-way ANOVA.
| Serial no. | Data | Mean±standard deviation (pg/L) | P value |
|---|---|---|---|
| 1 | Group 1 | 252.82±87.91 | 0.000* |
| Group 2 | 452.06±54.18 | ||
| 2 | Group 2 | 452.06±54.18 | 0.000* |
| Group 3 | 558.87±68.99 | ||
| 3 | Group 3 | 558.87±68.99 | 0.000* |
| Group 1 | 252.82±87.91 | ||
| Group 1, healthy; group 2, periodontitis; group 3, periodontitis with diabetes mellitus. * | |||






